HB126 Relative to prescriptions for certain controlled drugs.
Relative to prescriptions for certain controlled drugs.
Impact Score — How Does This Bill Affect You?
Overall Impact Score
Mixed
Scale: 1 (harmful) to 10 (beneficial)
Your Wallet
Patients requiring testosterone injections may see modest savings from fewer pharmacy visits and potential bulk-dispensing efficiencies, though the bill does not specify whether insurance copays change.
Your Community
The bill has no stated impact on schools, local services, or community infrastructure.
Your Freedom
The bill expands treatment access and reduces regulatory burden on a specific patient population by permitting longer supply fills for a medical condition, increasing patient autonomy in medication management.
Status
Signed by Governor Ayotte 05/22/2026; Chapter 80; eff. 07/21/2026
Sponsor
Daniel Popovici-Muller (R)
The Short Version
This bill modifies New Hampshire's controlled substance prescription limits by clarifying existing exceptions and adding a new one: pharmacists may now fill prescriptions for up to 92 days of injectable androgens for chronic low testosterone treatment, whereas the standard limit is 34 days. The bill primarily affects men receiving testosterone injections by reducing the frequency of pharmacy visits and refills needed.
Who's Behind This Bill?
Who Benefits
- ▲ Men with chronic low testosterone prescribed injectable androgens
- ▲ Pharmacists dispensing these medications (reduced administrative burden)
- ▲ Patients who benefit from fewer required pharmacy visits for this treatment
Who Pays the Price
- ▼ No identifiable group bears a direct cost from this bill
Bill statuses as of October 7, 2026. Check LegiScan or NH General Court for the latest.
This bill was auto-scored using AI analysis of the bill text and legislative data. Scores may be refined as we review more bills.